Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05587361 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Beta-Adrenergic Modulation of Drug Cue Reactivity

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Mar 1, 2026 to Mar 31, 2027v9
  2. Primary and study completion dates: Mar 30, 2025 to Mar 1, 2026
    • Start date: Nov 20, 2024 to Nov 26, 2024
    v8
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 1, 2024 to Nov 20, 2024
    • Site details revised
    v7
  4. Start date: Jun 1, 2024 to Nov 1, 2024
    • Site contact updated
    v6
  5. Start date: Apr 15, 2024 to Jun 1, 2024
    • Primary and study completion dates: Nov 1, 2025 to Mar 30, 2025
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Jan 15, 2024 to Apr 15, 2024v4
  2. Start date: Jun 15, 2023 to Jan 15, 2024v3
  3. Start date: Nov 1, 2022 to Jun 15, 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is designed to investigate the effects of a beta-adrenergic antagonist (Propranolol; 40 mg IR) and nicotine patch (14 mg) administered alone and in combination on neurobiological and behavioral responses to smoking cues in ongoing cigarette smokers. This is a basic experimental study in humans and participants will not take these medications for an extended period or make a cessation attempt as part of their involvement in this research project.
Trial Details
NCT Number NCT05587361
Lead Sponsor University of Oklahoma
Collaborators: Oklahoma State University Center for Health Sciences, Duke University, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)
Conditions
(from sponsor)		 Tobacco Use Disorder, Nicotine Dependence, Cigarette Smoking
Related terms Cigarette Smoking, Tobacco Use Disorder
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov